Prevention of delayed graft function after solid organ transplantation

On 22 February 2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 435. The active ingredient is recombinant human C1-inhibitor for prevention of delayed graft function after solid organ transplantation.